• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Medaro Mining Corp
Midnight Sun Mining Corp
Shanghai Fosun Pharmaceutical Group CO Ltd
Edit Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Profound Medical Corp (TSX:PRN)

8.250 -0.290 (-3.40%)
Delayed Quote Updated: 3:59 PM EDT, Oct 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 15,929
Open 9.070
Bid (Size) 8.220 (1)
Ask (Size) 9.080 (26)
Prev. Close 8.540
Today's Range 8.250 - 9.070
52wk Range 6.520 - 12.40
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
TULSA Abstracts at the 15th Interventional MRI Symposium Strengthen Real-World Evidence, Clinical Differentiation, and Platform Expansion Opportunity
October 14, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care
October 09, 2026
From Profound Medical Corp.
Via GlobeNewswire

Performance

52-Week Range 33.5% below 52-week high
8.250
6.5252W Low 12.4052W High
1 Week 20.3% below 1-week high
8.251W Low 10.351W High

Profound Medical Corp (PRN) traded between $6.52 and $12.40 over the past 52 weeks and last traded at $8.25, 33.5% below its 52-week high. Over the past week it ranged between $8.25 and $10.35.

Past 12 Months
-17.4%
-3.6%
-14.1%
-16.3%
-21.8%
+1.2%
1W -$1.74
1M -$0.31
3M -$1.35
6M -$1.61
YTD -$2.30
1Y +$0.10

PRN was +1.2% over the past year, -16.3% over six months, -21.8% year to date, -17.4% in the last week.

12 Months vs Market
PRN
+1.2%
DIA
+11.1%
SPY
+14.2%
QQQ
+17.5%
IWM
+9.3%

Over the past 12 months PRN returned +1.2% versus DIA (Dow) +11.1%, SPY (S&P 500) +14.2%, QQQ (Nasdaq 100) +17.5% and IWM (Russell 2000) +9.3%.

Volume & Liquidity 1.14× 3-mo avg
Today 15,929 3-mo avg 14.0K
1W
15.2K
1M
11.6K
3M
14.0K
6M
13.1K
YTD
15.2K
1Y
15.7K

PRN most recently traded 15,929 shares against a 3-month average daily volume of 14.0K.

More News

Read More
News headline image
Profound Medical Reports Strong Preliminary Third Quarter 2026 Revenue
October 07, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Participate in Lake Street’s 10th Annual Best Ideas Growth Conference
September 03, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Further Strengthens Executive Leadership Team with Appointment of Richard Fabian as President
September 01, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound’s Introduction of New Real-time Interventional MRI Software Paving the Way for Full ‘TULSA Days’
August 17, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Announces Management Change
August 14, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Launches ‘Let's Huddle’, a Global Community Supporting Men Throughout Their Prostate Care Journey
August 13, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Reports Second Quarter 2026 Financial Results
August 06, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Robotic Radical Prostatectomy Comes Up ‘Short’ in CAPTAIN Trial
July 24, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Release Second Quarter 2026 Financial Results on August 6th – Conference Call to Follow
July 16, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026
July 15, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches
May 15, 2026
From Telix Pharmaceuticals Limited
Via GlobeNewswire
News headline image
Profound to Showcase TULSA-PRO®, the TULSA Procedure™ and the Future of iMRI at AUA2026
May 14, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Reports Strong First Quarter 2026 Financial Results
May 07, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Release First Quarter 2026 Financial Results on May 7 – Conference Call to Follow
April 16, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference
April 14, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Incision-Free, MRI-Guided Prostate Treatment with Profound’s TULSA-PRO® to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting
April 01, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure™ Milestone
March 27, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
CAPTAIN Trial Comparing Profound’s MRI-Guided TULSA Procedure™ to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence
March 13, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Upcoming Meeting Dates - March 23, 2026
March 23, 2026
Via Newsfile
News headline image
Profound Medical to Host Investor Call to Discuss First Clinical Outcomes from the CAPTAIN Trial on March 13; Participate in ROTH Investor Conference on March 22-24
March 09, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Reports Fourth Quarter and Full Year 2025 Financial Results
March 05, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th – Conference Call to Follow
February 12, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Honored with INOVAIT’s 2025–2026 Mount Logan Award Recognizing the TULSA Procedure™ for Prostate Disease
February 12, 2026
From Profound Medical Corp.
Via GlobeNewswire

Frequently Asked Questions

Is Profound Medical Corp publicly traded?
Yes, Profound Medical Corp is publicly traded.
What exchange does Profound Medical Corp trade on?
Profound Medical Corp trades on the Toronto Stock Exchange
What is the ticker symbol for Profound Medical Corp?
The ticker symbol for Profound Medical Corp is PRN on the Toronto Stock Exchange
What is the current price of Profound Medical Corp?
The current price of Profound Medical Corp is 8.250
When was Profound Medical Corp last traded?
The last trade of Profound Medical Corp was at 10/19/26 03:59 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap